These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34106799)

  • 1. Leukocyte differential and reactive lymphocyte counts from Sysmex XN analyzer in the evaluation of SARS-CoV-2 infection.
    Urrechaga E; Mugertza G; Fernández M; España PP; Aguirre U
    Scand J Clin Lab Invest; 2021 Sep; 81(5):394-400. PubMed ID: 34106799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemocytometric characteristics of COVID-19 patients with and without cytokine storm syndrome on the sysmex XN-10 hematology analyzer.
    Martens RJH; van Adrichem AJ; Mattheij NJA; Brouwer CG; van Twist DJL; Broerse JJCR; Magro-Checa C; van Dongen CMP; Mostard RLM; Ramiro S; Landewé RBM; Leers MPG
    Clin Chem Lab Med; 2021 Mar; 59(4):783-793. PubMed ID: 33554540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil to CD4+ lymphocyte ratio as a potential biomarker in predicting virus negative conversion time in COVID-19.
    Wang H; Zhang Y; Mo P; Liu J; Wang H; Wang F; Zhao Q
    Int Immunopharmacol; 2020 Aug; 85():106683. PubMed ID: 32531713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between hematological parameters and disease severity in patients with SARS-CoV-2 infection.
    Lin S; Mao W; Zou Q; Lu S; Zheng S
    J Clin Lab Anal; 2021 Jan; 35(1):e23604. PubMed ID: 33184946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new haematocytometric index: Predicting severity and mortality risk value in COVID-19 patients.
    Kilercik M; Demirelce Ö; Serdar MA; Mikailova P; Serteser M
    PLoS One; 2021; 16(8):e0254073. PubMed ID: 34351940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte cell population as a potential hematological index for early diagnosis of COVID-19.
    Zhu Y; Cao X; Lu Y; Xu D; Lu R; Li X
    Cell Mol Biol (Noisy-le-grand); 2020 Oct; 66(7):202-206. PubMed ID: 33287943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of the neutrophil-to-lymphocyte ratio and C-reactive protein level for coronavirus disease 2019 (COVID-19).
    Yufei Y; Mingli L; Xuejiao L; Xuemei D; Yiming J; Qin Q; Hui S; Jie G
    Scand J Clin Lab Invest; 2020 Nov; 80(7):536-540. PubMed ID: 32804580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A meta-analysis of SARS-CoV-2 patients identifies the combinatorial significance of D-dimer, C-reactive protein, lymphocyte, and neutrophil values as a predictor of disease severity.
    Singh K; Mittal S; Gollapudi S; Butzmann A; Kumar J; Ohgami RS
    Int J Lab Hematol; 2021 Apr; 43(2):324-328. PubMed ID: 33010111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blast flagging of the Sysmex XN-10 hematology analyzer with supervised cell image analysis: Impact on quality parameters.
    Petrone J; Jackups R; Eby CS; Shimer G; Anderson J; Frater JL
    Int J Lab Hematol; 2019 Oct; 41(5):601-606. PubMed ID: 31162809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between leukocyte, neutrophil, lymphocyte, platelet counts, and neutrophil to lymphocyte ratio and polymerase chain reaction positivity.
    Kabak M; Çil B; Hocanlı I
    Int Immunopharmacol; 2021 Apr; 93():107390. PubMed ID: 33529907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4 and CD8 Lymphocyte Counts as Surrogate Early Markers for Progression in SARS-CoV-2 Pneumonia: A Prospective Study.
    Calvet J; Gratacós J; Amengual MJ; Llop M; Navarro M; Moreno A; Berenguer-Llergo A; Serrano A; Orellana C; Cervantes M
    Viruses; 2020 Nov; 12(11):. PubMed ID: 33182268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Routine laboratory testing to determine if a patient has COVID-19.
    Stegeman I; Ochodo EA; Guleid F; Holtman GA; Yang B; Davenport C; Deeks JJ; Dinnes J; Dittrich S; Emperador D; Hooft L; Spijker R; Takwoingi Y; Van den Bruel A; Wang J; Langendam M; Verbakel JY; Leeflang MM;
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD013787. PubMed ID: 33211319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of peripheral hematologic markers for coronavirus disease 2019 (COVID-19): A multicenter, cross-sectional study.
    Peng J; Qi D; Yuan G; Deng X; Mei Y; Feng L; Wang D
    J Clin Lab Anal; 2020 Oct; 34(10):e23475. PubMed ID: 32681559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are neutrophil-to-lymphocyte ratios and large unstained cells different in hospitalized COVID-19 PCR-positive patients with and without diabetes mellitus?
    Keskin M; Burcak Polat S; Ateş I; Izdeş S; Rahmet Güner H; Topaloğlu O; Ersoy R; Çakir B
    Eur Rev Med Pharmacol Sci; 2022 Aug; 26(16):5963-5970. PubMed ID: 36066173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced activity of B lymphocytes, recognised by Sysmex XN-2000™ haematology analyser, predicts mortality in patients with coronavirus disease 2019.
    Rolla R; Vidali M; Puricelli C; Scotta AM; Pedrinelli A; Pergolini P; Pirisi M; Dianzani U; Rigamonti C
    Int J Lab Hematol; 2021 Feb; 43(1):e5-e8. PubMed ID: 32893487
    [No Abstract]   [Full Text] [Related]  

  • 16. [Value of neutrophil-to-lymphocyte ratio in the classification diagnosis of coronavirus disease 2019].
    Fei M; Tong F; Tao X; Wang J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 May; 32(5):554-558. PubMed ID: 32576346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic implications of neutrophil-lymphocyte ratio in COVID-19.
    Jimeno S; Ventura PS; Castellano JM; García-Adasme SI; Miranda M; Touza P; Lllana I; López-Escobar A
    Eur J Clin Invest; 2021 Jan; 51(1):e13404. PubMed ID: 32918295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Usefulness of Extended Inflammation Parameters and Systemic Inflammatory Response Markers in the Diagnostics of Autoimmune Hepatitis.
    Domerecka W; Kowalska-Kępczyńska A; Homa-Mlak I; Michalak A; Mlak R; Mazurek M; Cichoż-Lach H; Małecka-Massalska T
    Cells; 2022 Aug; 11(16):. PubMed ID: 36010631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage.
    Liu J; Liu Y; Xiang P; Pu L; Xiong H; Li C; Zhang M; Tan J; Xu Y; Song R; Song M; Wang L; Zhang W; Han B; Yang L; Wang X; Zhou G; Zhang T; Li B; Wang Y; Chen Z; Wang X
    J Transl Med; 2020 May; 18(1):206. PubMed ID: 32434518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of cycle threshold time, absolute lymphocyte count and neutrophil:lymphocyte ratio is predictive of hypoxia in patients with SARS-CoV-2 infection.
    Abeysuriya V; Seneviratne SL; de Silva AP; Mowjood R; Mowjood S; de Silva T; de Mel P; de Mel C; Chandrasena L; Wijesinha RS; Fernando A; de Mel S
    Trans R Soc Trop Med Hyg; 2022 Jul; 116(7):628-635. PubMed ID: 34894631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.